| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
821
|
2,184
|
1,714
|
1,841
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
821
|
2,184
|
1,714
|
1,841
| |
|
Operating Expenses |
|
Research Development | 9,834 | 9,858 | 8,798 | 8,242 |
|
Selling General and Administrative | 3,634 | 3,815 | 2,990 | 2,568 |
|
Non Recurring |
-
|
-
| (2) | (13) |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(12,647)
|
(11,489)
|
(10,072)
|
(8,956)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 28 | 33 | 28 | 14 |
|
Earnings Before Interest And Taxes | (12,619) | (11,456) | (10,044) | (8,942) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (12,619) | (11,456) | (10,044) | (8,942) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (12,619) | (11,456) | (10,044) | (8,942) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(12,619)
|
(11,456)
|
(10,044)
|
(8,942)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (1,307) | | |
Net Income Applicable To Common Shares
|
(12,619)
|
(11,456)
|
(10,044)
|
(10,249)
|
|
0.04(2.06%) 9:50AM EDT - Nasdaq Real Time Price